Differential Pharmacological Impacts of Antiretrovirals upon Platelet and Endothelial Activation to Establish Mechanisms of Cardiovascular Risk in People Living with HIV
ISTH Academy, Michael Emerson, 264349
A Diabetic Microvascular Whole Blood Flow Model as a New Tool to Study Diabetes-Associated Thrombotic Complications
ISTH Academy, Verena Schroeder, 264351
Performance of point-of care INR as part of pre-thrombolysis laboratory panel
ISTH Academy, Tuukka Helin, 264370
Isolated A2 domain of von Willebrand factor binds to stimulated endothelial cells via vimentin, promoting cell signals
ISTH Academy, Marina Martinez-Vargas, 264371
Paediatric factor VIII and IX reference intervals using STA®-ImmunoDef VIII and STA®-ImmunoDef IX
ISTH Academy, Natasha Letunica, 264387
Additive effect on the global clotting function in moderate/mild hemophilia A by addition of emicizumab, evaluated by clot waveform analysis
ISTH Academy, Yuto Nakajima, 264388
A Novel Plasma Panel for the Assessment of Chronic Liver Disease Severity
ISTH Academy, Vladimir Bogdanov, 264404
Efficiency of anticoagulant protein C system in patients with Primary Myelofibrosis
ISTH Academy, Olesia Matvienko, 264405
Determining the contribution of FXa activation of FV to thrombin generation using TIX-5: variation in healthy controls and association of high TIX-5 sensitivity with complications in patients on vitamin K antagonists (VKAs)
ISTH Academy, Anja Maag, 264422
Thrombosis Initiation Examined Through a Flexible 3D non-Newtonian Computational Framework
ISTH Academy, Sabrina R. Lynch, 264423
Variation of rs3754689 at lactase gene and inhibitors in admixed Brazilian patients with hemophilia A
ISTH Academy, Daniel G. Chaves, 264442
Effect of Standard and Intensive Insulin Therapy on Membrane-Bound Tissue Factor and Plasma Coagulation Biomarkers in Patients with Hyperglycemia and Acute Stroke: Differential Effects of rtPA Administration
ISTH Academy, A Koneti Rao, 264443
Patterns of JAK2-V617F testing and predictive value of erythropoietin in adult erythrocytosis: Experience at a comprehensive cancer center
ISTH Academy, Cristhiam Mauricio Rojas Hernandez, 264461
To describe D-dimer levels in patients receiving direct oral anticoagulants with and without suspected recurrence of venous thromboembolism
ISTH Academy, Patrick Leung, 264462
specific protein plasma profile associated to venous thromboembolism
ISTH Academy, Julia Oto, 264478
Deep Vein Thrombosis Metabolomic Profiling by 1H NMR
ISTH Academy, Melissa Quintero, 264479
Next Generation Sequencing as a new tool to improve molecular diagnosis of VWD
ISTH Academy, Christophe Zawadzki, 264495
Evaluation of emicizumab calibrator and controls with a modified one-stage FVIII assay on an automated coagulation analyzer
ISTH Academy, Sho Shinohara, 264496
Non-EDTA dependent pseudotrombocytopenia
ISTH Academy, Gian Luca Salvagno, 264512
Standardization of Light Transmission Aggregometry for the diagnosis of inherited platelet function disorders: First inter-laboratory external quality assessment in Germany and Austria
ISTH Academy, Karina Althaus, 264513
Fibrin Clots Containing NETs Show Slower Fibrinolysis and Are Stiffer in Patients with Diabetes
ISTH Academy, Judith Juliana de Vries, 264532
Fibrin clot lysis analysis; tissue factor versus thrombin as activator
ISTH Academy, Mai Stenulm Veirup, 264533
Indications and Outcomes of Thrombolytic Therapy 2010-2016: A Retrospective Single Center Study
ISTH Academy, Peter Verhamme, 264551
Immunoadsorption for the treatment of acquired haemophilia: new observational data, systematic review, and meta-analysis
ISTH Academy, Michael Nagler, 264554
Acquired VKOR inhibitor: A New Entity?
ISTH Academy, Veena Selvaratnam, 264569
The Paradox : Bleeding Presentation in Antiphospholipid Syndrome
ISTH Academy, Veena Selvaratnam, 264570
Predictive value of soluble fibrin and new diagnostic criteria by the Japanese Society on Thrombosis and Hemostasis (JSTH) for the prognosis of patients with sepsis-associated disseminated intravascular coagulation
ISTH Academy, Seiji Madoiwa, 264586
A Study of the Prognostic Value of Smartphone Application on Disseminated Intravascular Coagulation (DIC) Score in Prediction of 28-day Mortality
ISTH Academy, Tanapun Thamgrang, 264587
Validation of the Patient Reported Outcomes Burdens and Experiences (PROBE) study questionnaire
ISTH Academy, Mark Skinner, 264602
Evaluation of active genetic counseling service for female family members of hemophilia patients in Korea
ISTH Academy, Hyon Kim, 264603
Identification of New Deep Intronic Variants Causing Hemophilia A by Whole F8 Gene Sequencing, mRNA Analysis and Functional Confirmation, in “Variant-Negative” French and Canadian Patients
ISTH Academy, Fanny Lassalle, 264604
Clinical Use of Recombinant Factor VIII Fc (rFVIII-Fc) in Patients with Haemophilia A in a Single Centre
ISTH Academy, Segolene Claeyssens, 264618
The Estimated Impact of New Therapies on Factor VIII (FVIII) Use and Product Cost by 2023
ISTH Academy, Jonathan Ducore, 264619
AHEAD International and German Studies: Subgroup Analysis of Patients with Moderate or Severe Hemophilia A Receiving Antihemophilic Factor (Recombinant) as Immune Tolerance Induction (ITI) Therapy
ISTH Academy, Margareth C. Ozelo, 264620
Outcomes with an Extended Prophylactic Treatment Schedule of Rurioctocog Alfa Pegol in a Phase 3b, Open-label, Multicenter, CONTINUATION Study in Previously Treated Patients with Severe Hemophilia A
ISTH Academy, Srilatha Tangada, 264635
A fixed “single vial” dose of 15 micrograms of subcutaneous desmopressin (SC-DDAVP) produces adequate biologic responses for persons with mild haemophilia A
ISTH Academy, Jane Mason, 264636
Current status of hemophilia in China
ISTH Academy, Xuewen Song, 264637
Clinical assessment with focus on health-related quality of life in adult patients with severe hemophilia B
ISTH Academy, Anna Buczma, 264651
Acquired haemophilia still remains a complex clinical challenge
ISTH Academy, Claudia Cristina Tarniceriu, 264652
6 Consecutive Patients and 100% of Inhibitors: is Inhibitor Development Inevitable?
ISTH Academy, Cristina Catarino Oliveira, 264653
Real-world use of 4-factor prothrombin complex concentrates (4F-PCC) in warfarin-associated intracranial haemorrhage patients in Hong Kong: a descriptive patient management protocol
ISTH Academy, Wing Chi Fong, 264671
Management of Antithrombotic Therapy After Gastrointestinal Bleeding: A Qualitative Study of Healthcare Providers
ISTH Academy, Deborah Siegal, 264672
Perioperative Management of Antiplatelets and Anticoagulants in Elective Surgery
ISTH Academy, James Sindone, 264673
Involvement of Glycoprotein VI in platelet mediated amyloid-β fibril formation
ISTH Academy, Lili Donner, 264687
Regulation of NET formation by von Willebrand factor
ISTH Academy, Kimberly Martinod, 264688
Impairment of Erythrocyte Deformability Observed in Type 2 Diabetic Patients with Clustering Diabetic Complications
ISTH Academy, Toru Maruyama, 264689
Coagulation and fibrinolysis waveform analysis may identify the patients susceptible for multiple organ failure and thrombocytopenia in septic DIC
ISTH Academy, Noritaka Yada, 264705
Pro-inflammatory Macrophage Polarization enhances Neutrophil Extracellular Trap Degradation
ISTH Academy, Patrick Haider, 264706
Investigating the role of neutrophils and NETs in Staphylococcus aureus endocarditis
ISTH Academy, Severien Meyers, 264707
A Proposed 'ABN Score' for Prediction of Aspirin Resistance in Thai Patients with Polycythemia Vera and Essential Thrombocythemia
ISTH Academy, Yingyong Chinthammitr, 264721
Do paracetamol and nonsteroidal anti-inflammatory drugs affect the quality of platelets for transfusion?
ISTH Academy, Dianne E. van der Wal, 264722
APAC, a dual antiplatelet and anticoagulant - towards a local, vascular targeting antithrombotic
ISTH Academy, Riitta Lassila, 264723
Assessment of platelet function after shear stress simulation using ex vivo closed-loop ECC model (modified Chandler-Loop)
ISTH Academy, Jan Zlamal, 264739
Deciphering the molecular interactions of Streptococcus gordonii with human platelets and endothelial cells in the context of infective endocarditis
ISTH Academy, Sylviane Yoba, 264740
The integrin αIIbβ3 signalling pathway is hyperactivated in platelets from obese patients: a phosphoproteomic study
ISTH Academy, Maria Nuñez Barrachina, 264741
Phosphate-induced ORAI1 expression and store operated Ca2+ entry in megakaryocytes
ISTH Academy, Tamam Bakchoul, 264755
Simultaneous quantification of oxygen radicals and platelet aggregation highlights the importance of NADPH oxidases in the regulation of thrombus formation in health and disease
ISTH Academy, Giordano Pula, 264757
Study of calcium signaling dynamics in single platelets
ISTH Academy, Daria Spiryova, 264758
Analytical Performance Validation of a new screening assay for the deficiency of ADAMTS-13 Activity
ISTH Academy, Nikolaus Bernhard Binder, 264774
Feasibility of a new fully automated ADAMTS-13 activity assay
ISTH Academy, Marcos Llusa, 264775
Feasibility study for subcutaneous route of administration of recombinant ADAMTS13 (TAK-755/SHP655)
ISTH Academy, Werner Hoellriegl, 264776
Successful International Standardisation of ADAMTS13 Assays Highlights Challenges in the Result Interpretation for the Diagnosis of Thrombotic Thrombocytopenic Purpura (TTP) - results of the Asia-Pacific Microangiopathic (APMAT) Network
ISTH Academy, Jim Y Tiao, 264791
Time from Suspected Thrombotic Thrombocytopenic Purpura to Initiation of Plasma Exchange in Alberta, Canada and Impact on Survival: 10-year Provincial Retrospective Cohort Study
ISTH Academy, Haowei Sun, 264792
The Incidence of Low ADAMTS13 Activity in Systemic Lupus Erythematosus Patients with Thrombocytopenia
ISTH Academy, theera ruchutrakool, 264793
Efficacy and Safety of Bronchial Artery Embolization on Hemoptysis in Chronic Thromboembolic Pulmonary Hypertension: A Pilot Prospective Cohort Study
ISTH Academy, Suqiao Yang, 264807
The independent effect of being a strict stockings complier on the outcome of the SOX Trial
ISTH Academy, Susan R. Kahn, 264808
External validation of the SOX-PTS score (clinical prediction model for the post-thrombotic syndrome) in a prospective multicenter study of patients with proximal deep vein thrombosis
ISTH Academy, Susan R. Kahn, 264809
Diagnostic Performance of Current Imaging Modalities for Diagnosing Cerebral Vein Thrombosis
ISTH Academy, Lisette F. van Dam, 264825
Decline in Periprocedural Anticoagulant Use in Warfarin-treated VTE Patients following the BRIDGE Trial Publication
ISTH Academy, Geoffrey Barnes, 264826
Cost Savings Associated with Extended INR Testing Intervals
ISTH Academy, Scott Kaatz, 264827
Incidences of thrombosis, major bleeding and 30-day mortality in patients receiving veno-venous extracorporeal membrane oxygenation and value of laboratory parameters at presentation in predicting outcomes
ISTH Academy, Deepa Jayakody Arachchillage, 264841
The PECAN study: Diagnosing Pulmonary Embolism in the context of Common Alternative diagNoses in primary care
ISTH Academy, Rosanne van Maanen, 264842
Treatment of PICC-related upper limb deep-vein or superficial vein thrombosis with Edoxaban. Rationale and protocol
ISTH Academy, Cristiano Bortoluzzi, 264843
Influence of polymorphisms in the CYP2C9, VKORC1, MDR1 and APOE genes and other patient variables on warfarin dose in patients treated at anticoagulation clinics in Brazil
ISTH Academy, Luci Dusse, 264858
Diagnostic accuracy of limited versus whole-leg ultrasonography for suspected deep vein thrombosis: a systematic review and meta-analysis
ISTH Academy, Noémie Kraaijpoel, 264859
Brazilian version of the oral anticoagulation knowledge test: an item response theory approach
ISTH Academy, Luci Dusse, 264860
Activated partial thromboplastin time-based unfractionated heparin dosing protocol for pregnant patients
ISTH Academy, Reiko Neki, 264880
Profiling of hypercoagulability biomarkers and development of a new Risk Assessment Model for the identification of outcome of in vitro fertilization. The ROADMAP-IVF study
ISTH Academy, Patrick Van Dreden, 264881
Current ISTH Registries on Women´s Health Issues in Thrombosis and Haemostasis: Powerful Tools for Improved Data Collection and Outcome Measurement
ISTH Academy, Maha Othman, 264882
Risk of pregnancy- related thromboembolism and obstetrical complications in women with type I antithrombin deficiency
ISTH Academy, Marco Capecchi, 264900
Is the Resolution of Inflammation Altered in Preeclampsia?
ISTH Academy, Luci Dusse, 264901
An obstetric thrombophilia patient with heterozygous factor V Leiden (A1691G) and homozygous C677T MTHFR mutations in family history; case report and literature review
ISTH Academy, Justyna Teliga-Czajkowska, 264902
New Method to Test Protein S
ISTH Academy, Eriko Morishita, 275000
Use of Protein C Concentrates
ISTH Academy, Leonardo Brandao, 275001
Discussion for Future Projects
ISTH Academy, Jun Teruya, 275002
ISTH Academy, Kathleen Freson, 275003
Tier1 Genes and Gold Variants for Bleeding, Thrombotic and Platelet Disorders
ISTH Academy, Karyn Megy, 275004
The ClinGen Working Group for Thrombosis and Hemostasis
ISTH Academy, Jorge Di Paola, 275005
Diagnostics of Inherited Thrombocytopenia: A Clinical Perspective
ISTH Academy, Patrizia Noris, 275006
Finding Consensus in Defining Trauma Induced Coagulopathy: Part 2
ISTH Academy, Beverley Hunt, 275016
Bridging the Gap to Find Consensus on Trauma Induced Coagulopathy Nomenclature: Updates from the Tranexamic Acid/Trauma Symposia
ISTH Academy, Dominik Drexler, 275017
Open Discussion: SSC Consensus Statement on Trauma Induced Coagulopathy
ISTH Academy, Paul Kim, 275018
Welcome: Outline of the Women’s SSC and Overview of Activities
ISTH Academy, Maha Othman, 275019
Challenges in the Management of Von Willebrand Disease in Pregnancy: Results from an International Survey
ISTH Academy, Michelle Lavin, 275020
Hemophilia Carrier Nomenclature: Proposed Terminology to Improve Communication
ISTH Academy, Robert Fran Sidonio Jr., 275021
Assessment of Fibrinolysis in Sepsis
ISTH Academy, Ecaterina Scarlatescu, 275034
ISTH Academy, John-Bjarne Hansen, 275035
Standardized Assessment of Bleeding Risk in Venous Thromboembolism Patients Initiating Anticoagulant Treatment
ISTH Academy, Geert-Jan Geersing, 275039
Biomarkers for and Prediction of Venous Thromboembolism After Stroke
ISTH Academy, Vânia Maris Morelli, 275040
Prediction of Death in Acute Pulmonary Embolism
ISTH Academy, Stefano Barco, 275041

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings